<i>Strongyloides stercoralis</i>: A Neglected but Fatal Parasite by Viravarn Luvira, Tanaya Siripoon, Danabhand Phiboonbanakit, Kollawat Somsri, Dorn Watthanakulpanich, Paron Dekumyoy

Get full text

Temporal Trend of COVID-19 Vaccine Acceptance and Factors Influencing International Travellers by Manasvin Onwan, Wasin Matsee, Saranath Lawpoolsri, Phimphan Pisutsan, Tanaya Siripoon, Suda Punrin, Watcharapong Piyaphanee

Get full text

Clinical and immunological characteristics for BK polyomavirus‐associated nephropathy after kidney transplantation by Tanaya Siripoon, Nopporn Apiwattanakul, Pannawat Mongkolrattanakul, Chutatip Tongsook, Nattawut Unwanatham, Suradej Hongeng, Surasak Kantachuvesiri, Jackrapong Bruminhent

Get full text

Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccinat... by Prapassorn Poolchanuan, Wasin Matsee, Sineenart Sengyee, Tanaya Siripoon, Adul Dulsuk, Rungnapa Phunpang, Phimphan Pisutsan, Watcharapong Piyaphanee, Viravarn Luvira, Narisara Chantratita

Get full text

Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial by Viravarn Luvira, William H. K. Schilling, Podjanee Jittamala, James A. Watson, Simon Boyd, Tanaya Siripoon, Thundon Ngamprasertchai, Pedro J. Almeida, Maneerat Ekkapongpisit, Cintia Cruz, James J. Callery, Shivani Singh, Runch Tuntipaiboontana, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Srisuda Keayarsa, Wanassanan Madmanee, Renato S. Aguiar, Franciele M. Santos, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mallika Imwong, Walter R. J. Taylor, Vasin Chotivanich, Kesinee Chotivanich, Sasithon Pukrittayakamee, Arjen M. Dondorp, Nicholas P. J. Day, Mauro M. Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J. White, the PLATCOV Collaborative Group

Get full text

Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV) by William HK Schilling, Podjanee Jittamala, James A Watson, Maneerat Ekkapongpisit, Tanaya Siripoon, Thundon Ngamprasertchai, Viravarn Luvira, Sasithorn Pongwilai, Cintia Cruz, James J Callery, Simon Boyd, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Yazid Abdad, Nattaporn Piaraksa, Kanokon Suwannasin, Pongtorn Hanboonkunupakarn, Borimas Hanboonkunupakarn, Sakol Sookprome, Kittiyod Poovorawan, Janjira Thaipadungpanit, Stuart Blacksell, Mallika Imwong, Joel Tarning, Walter RJ Taylor, Vasin Chotivanich, Chunlanee Sangketchon, Wiroj Ruksakul, Kesinee Chotivanich, Mauro Martins Teixeira, Sasithon Pukrittayakamee, Arjen M Dondorp, Nicholas PJ Day, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J White, on behalf of the PLATCOV Collaborative Group

Get full text